Amyris Inc (NASDAQ:AMRS) Stock Position Lessened by Pinnacle Associates Ltd.

Share on StockTwits

Pinnacle Associates Ltd. decreased its holdings in Amyris Inc (NASDAQ:AMRS) by 9.4% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 450,782 shares of the biotechnology company’s stock after selling 46,723 shares during the quarter. Pinnacle Associates Ltd. owned 0.59% of Amyris worth $1,605,000 as of its most recent filing with the SEC.

Several other large investors have also added to or reduced their stakes in AMRS. Bank of New York Mellon Corp boosted its position in shares of Amyris by 17.0% during the 4th quarter. Bank of New York Mellon Corp now owns 134,975 shares of the biotechnology company’s stock worth $451,000 after purchasing an additional 19,587 shares in the last quarter. Northern Trust Corp boosted its position in shares of Amyris by 7.5% during the 4th quarter. Northern Trust Corp now owns 387,984 shares of the biotechnology company’s stock worth $1,296,000 after purchasing an additional 27,152 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Amyris by 6.7% during the 4th quarter. Geode Capital Management LLC now owns 408,253 shares of the biotechnology company’s stock worth $1,363,000 after purchasing an additional 25,492 shares in the last quarter. Principal Financial Group Inc. purchased a new stake in shares of Amyris during the 4th quarter worth $109,000. Finally, Bank of America Corp DE raised its stake in shares of Amyris by 359.2% during the 4th quarter. Bank of America Corp DE now owns 49,575 shares of the biotechnology company’s stock worth $165,000 after buying an additional 38,780 shares during the last quarter. 34.60% of the stock is owned by institutional investors.

Separately, BidaskClub raised Amyris from a “sell” rating to a “hold” rating in a research note on Tuesday, August 13th.

NASDAQ:AMRS opened at $4.06 on Friday. The company has a market capitalization of $310.71 million, a PE ratio of -1.60 and a beta of 1.04. Amyris Inc has a 52-week low of $1.87 and a 52-week high of $9.28. The stock has a fifty day simple moving average of $3.27 and a 200-day simple moving average of $3.82.

Amyris Company Profile

Amyris, Inc, an integrated renewable products company, delivers alternatives to petroleum, plant, and animal-based products across a range of consumer and industry segments worldwide. It applies its bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients, and consumer products.

Further Reading: Understanding Analyst Ratings

Want to see what other hedge funds are holding AMRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amyris Inc (NASDAQ:AMRS).

Institutional Ownership by Quarter for Amyris (NASDAQ:AMRS)

Receive News & Ratings for Amyris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amyris and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Family Management Corp Acquires 431 Shares of Mcdonald’s Corp
Family Management Corp Acquires 431 Shares of Mcdonald’s Corp
Family Management Corp Increases Stock Holdings in Nuveen Arizona Premium Income Mun Fd
Family Management Corp Increases Stock Holdings in Nuveen Arizona Premium Income Mun Fd
Family Management Corp Has $383,000 Stock Holdings in Invesco Variable Rate Preferred ETF
Family Management Corp Has $383,000 Stock Holdings in Invesco Variable Rate Preferred ETF
Family Management Corp Sells 850 Shares of Bristol-Myers Squibb Co
Family Management Corp Sells 850 Shares of Bristol-Myers Squibb Co
CPV Partners LLC Buys New Holdings in Laureate Education Inc
CPV Partners LLC Buys New Holdings in Laureate Education Inc
Family Management Corp Increases Stake in Blackrock Muniholdings New York Qulty Fd
Family Management Corp Increases Stake in Blackrock Muniholdings New York Qulty Fd


© 2006-2019 Ticker Report